Sector ratings Bio-Rad Laboratories, Inc.

Stocks

Market Closed - NYSE 06:00:03 21/08/26 am AEST			5-day change	1st Jan Change
376.46 ^USD	+3.35%		+4.23%	+24.25%

07/08	RBC Adjusts PT on Bio-Rad Laboratories to $390 From $370, Maintains Outperform Rating	MT
05/08	RBC Adjusts Price Target on Bio-Rad Laboratories to $370 From $320, Maintains Outperform Rating	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	ESG MSCI	Global Valuation
BIO-RAD LABORATORIES, INC.	10.01B	BBB	-
ABBOTT LABORATORIES	198B	BBB
MEDTRONIC PLC	118B	BBB
CENCORA, INC.	60.05B	AA
HOYA CORPORATION	53.18B	AAA
BECTON, DICKINSON AND COMPANY	51.11B	A
DEXCOM, INC.	34.05B	BBB
MEDLINE INC.	28.58B	A
WEST PHARMACEUTICAL SERVICES, INC.	24.9B	AA
STERIS PLC	22.98B	AAA	-
TERUMO CORPORATION	23.94B	AA
SARTORIUS STEDIM BIOTECH	22.16B	BBB
ZIMMER BIOMET HOLDINGS, INC.	18.88B	A
SOLVENTUM CORPORATION	15.08B	BBB
FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED	15.01B	A
BAXTER INTERNATIONAL INC.	13.65B	A
GLOBUS MEDICAL, INC.	11.5B	CCC
ALIGN TECHNOLOGY, INC.	11.29B	A
INSULET CORPORATION	10.19B	A
REPLIGEN CORPORATION	10.17B	AA
Average	37.62B	A
Weighted average by Cap.		A